TY  - GEN
AU  - Arosh,Joe A
AU  - Lee,JeHoon
AU  - Balasubbramanian,Dakshnapriya
AU  - Stanley,Jone A
AU  - Long,Charles R
AU  - Meagher,Mary W
AU  - Osteen,Kevin G
AU  - Bruner-Tran,Kaylon L
AU  - Burghardt,Robert C
AU  - Starzinski-Powitz,Anna
AU  - Banu,Sakhila K
TI  - Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis
SN  - 1091-6490
PY  - 2015///1117
KW  - Animals
KW  - Apoptosis
KW  - drug effects
KW  - Biphenyl Compounds
KW  - pharmacology
KW  - Caspase 3
KW  - metabolism
KW  - Cell Line
KW  - Cell Movement
KW  - Cell Survival
KW  - Disease Models, Animal
KW  - Endometriosis
KW  - drug therapy
KW  - Endometrium
KW  - blood supply
KW  - Estrogens
KW  - biosynthesis
KW  - Female
KW  - Humans
KW  - Inflammation
KW  - pathology
KW  - Mice
KW  - Neovascularization, Pathologic
KW  - Pelvic Pain
KW  - Poly(ADP-ribose) Polymerases
KW  - Progesterone
KW  - Receptors, Prostaglandin E, EP2 Subtype
KW  - antagonists & inhibitors
KW  - Receptors, Prostaglandin E, EP4 Subtype
KW  - Signal Transduction
KW  - Steroids
KW  - therapeutic use
KW  - Xanthones
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1073/pnas.1507931112
ER  -